EGFR and breast carcinoma: Here we demonstrated that CH12 had a significant growth-suppression effect on EGFRvIII+HER2+ breast cancers in vitro and in vivo (Figure 3A and 3B) at least partially through inhibiting the phosphorylation of EGFR, AKT and STAT3 (Figure 3C and 3D).